STAAR Surgical Announces Strategic Agreement in U.S. with SharpeVision
View the full release here: https://www.businesswire.com/news/home/20240123947715/en/
- View the full release here: https://www.businesswire.com/news/home/20240123947715/en/
STAAR Surgical and SharpeVision will collaborate on marketing and education activities to elevate awareness of EVO ICL and significantly increase availability of the lenses to all qualified patients in SharpeVision clinics. - STAAR Surgical will also provide additional practice development and clinical support.
- “We are pleased to announce SharpeVision as a new partner under our U.S. Highway 93 go-to-market program initiated in October 2023.
- Naves, J. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery.